ARS Investment Partners’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-40,765
Closed -$115K – 185
2025
Q4
$115K Sell
40,765
-19,242
-32% -$99.2K 0.01% 189
2025
Q3
$418K Buy
60,007
+3,500
+6% +$24.7K 0.03% 126
2025
Q2
$335K Buy
56,507
+32,166
+132% +$185K 0.02% 137
2025
Q1
$289K Hold
24,341
– – 0.03% 139
2024
Q4
$289K Sell
24,341
-246
-1% -$4.19K 0.03% 139
2024
Q3
$681K Sell
24,587
-897
-4% -$22.4K 0.06% 97
2024
Q2
$608K Sell
25,484
-8,195
-24% -$192K 0.06% 97
2024
Q1
$593K Sell
33,679
-7,800
-19% -$115K 0.06% 94
2023
Q4
$655K Buy
41,479
+5,083
+14% +$52.5K 0.07% 89
2023
Q3
$313K Sell
36,396
-18,820
-34% -$134K 0.04% 117
2023
Q2
$436K Buy
55,216
+6,112
+12% +$42.5K 0.05% 111
2023
Q1
$366K Buy
49,104
+11,642
+31% +$116K 0.04% 114
2022
Q4
$442K Sell
37,462
-750
-2% -$8.57K 0.06% 95
2022
Q3
$352K Buy
38,212
+12,164
+47% +$147K 0.05% 118
2022
Q2
$257K Buy
26,048
+6,287
+32% +$127K 0.04% 123
2022
Q1
$681K Buy
19,761
+4,018
+26% +$130K 0.07% 94
2021
Q4
$784K Buy
15,743
+7,350
+88% +$387K 0.07% 91
2021
Q3
$386K Sell
8,393
-1,096
-12% -$43.4K 0.04% 115
2021
Q2
$284K Buy
+9,489
New +$194K 0.03% 125

Other funds holding ASPN

ARS Investment Partners's ASPN Position: Q1 2026 in Review

ARS Investment Partners sold out of Aspen Aerogels (ASPN) in Q1 2026, closing a stake of 40,765 shares — an estimated $115K sold.

ARS Investment Partners first reported a position in ASPN in Q2 2021 and held it in 19 quarters. The position peaked at $784K in Q4 2021. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.

  • ARS Investment Partners reported no remaining Aspen Aerogels position as of Q1 2026 after selling out during the quarter.
  • ARS Investment Partners sold 40,765 Aspen Aerogels shares in Q1 2026, an estimated $115K.
  • ARS Investment Partners first reported a position in Aspen Aerogels in Q2 2021 and held it in 19 quarters.
  • ARS Investment Partners's Aspen Aerogels position peaked at $784K in Q4 2021.
  • 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.

Based on ARS Investment Partners's 13F filing for Q1 2026, filed 16 Apr 2026.